Toggle navigation
Home
Publications
Publications
Authors
Institutions
Journals
Rankings
Authors
Institutions
Journals
About
FAQ
Links
Contacts
PT
Sign in
Article
Title:
Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
Authors:
Ana Teresa Paquete
(
U Lisboa
)
Luis Silva Miguel
(
U Lisboa
)
Ursula Becker
(
F Hoffman-La Roche Ltd, Basel
)
Catarina Pereira
(
Roche Farmaceutica Quimica, Lda, Lisbon
)
Carlos Gouveia Pinto
(
U Lisboa
)
Journal:
Applied Health Economics and Health Policy
Year:
2017
Volume:
15
Number:
4
Pages:
501-512
JEL codes:
I11 - Analysis of Health Care Markets
D61 - Allocative Efficiency; Cost?Benefit Analysis
DOI:
10.1007/s40258-017-0321-2
Back